{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:11Z","timestamp":1792788071130,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"UTRGV internal funding","award":["SC2GM139715"],"award-info":[{"award-number":["SC2GM139715"]}]},{"name":"UTRGV internal funding","award":["SC2GM139715"],"award-info":[{"award-number":["SC2GM139715"]}]},{"name":"National Institute of Health, USA","award":["R15NS108815 and R01AI147731"],"award-info":[{"award-number":["R15NS108815 and R01AI147731"]}]},{"name":"NASA-MUREP, NASA-MOSAIC, UTRGV-Resource Centers for Minority Aging Research","award":["P30AG059305"],"award-info":[{"award-number":["P30AG059305"]}]},{"name":"NIMHD grant","award":["U54MD019970"],"award-info":[{"award-number":["U54MD019970"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03713-6","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:06:24Z","timestamp":1772449584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Interferon-induced protein IFIT3 as a molecular nexus of neuroinflammation in Alzheimer\u2019s disease and HIV-associated neurocognitive disorders"],"prefix":"10.1186","volume":"23","author":[{"given":"Ranjit Kumar","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirakar","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansapani","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim K.","family":"Duttaroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerel Adam","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upal","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"3713_CR1","doi-asserted-by":"publisher","first-page":"742408","DOI":"10.3389\/fnagi.2022.742408","volume":"14","author":"MB Abubakar","year":"2022","unstructured":"Abubakar MB, et al. Alzheimer\u2019s disease: an update and insights into pathophysiology. Front Aging Neurosci. 2022;14:742408.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3713_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/14737175.2024.2415985","volume":"25","author":"A Parul","year":"2025","unstructured":"Parul A, Singh, Shukla S. Novel techniques for early diagnosis and monitoring of alzheimer\u2019s disease. Expert Rev Neurother. 2025;25(1):29\u201342.","journal-title":"Expert Rev Neurother"},{"key":"3713_CR3","doi-asserted-by":"publisher","first-page":"100478","DOI":"10.1016\/j.smhl.2024.100478","volume":"32","author":"Z Liu","year":"2024","unstructured":"Liu Z, et al. Explainable AI and transformer models: unraveling the nutritional influences on alzheimer\u2019s disease mortality. Smart Health. 2024;32:100478.","journal-title":"Smart Health"},{"issue":"1","key":"3713_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13195-022-01117-1","volume":"14","author":"AL Brand","year":"2022","unstructured":"Brand AL, Lawler PE, Bollinger JG, Li Y, Schindler SE, Li M, et al. The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer\u2019s disease: a literature review. Alzheimers Res Ther. 2022;14(1):195.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"3713_CR5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","volume":"2","author":"J Therriault","year":"2022","unstructured":"Therriault J, et al. Biomarker modeling of alzheimer\u2019s disease using PET-based Braak staging. Nat Aging. 2022;2(6):526\u201335.","journal-title":"Nat Aging"},{"issue":"4","key":"3713_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, et al. Staging of alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389\u2013404.","journal-title":"Acta Neuropathol"},{"issue":"8","key":"3713_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.122.265200","volume":"64","author":"AC Macedo","year":"2023","unstructured":"Macedo AC, et al. The use of Tau PET to stage alzheimer disease according to the Braak staging framework. J Nucl Med. 2023;64(8):1171\u20138.","journal-title":"J Nucl Med"},{"issue":"9","key":"3713_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.molmed.2022.05.008","volume":"28","author":"J Therriault","year":"2022","unstructured":"Therriault J, et al. Staging of alzheimer\u2019s disease: past, present, and future perspectives. Trends Mol Med. 2022;28(9):726\u201341.","journal-title":"Trends Mol Med"},{"issue":"9","key":"3713_CR9","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1093\/cercor\/bhy152","volume":"28","author":"H Braak","year":"2018","unstructured":"Braak H, Del K, Tredici. Spreading of Tau pathology in sporadic alzheimer\u2019s disease along cortico-cortical top-down connections. Cereb Cortex. 2018;28(9):3372\u201384.","journal-title":"Cereb Cortex"},{"key":"3713_CR10","doi-asserted-by":"publisher","first-page":"964075","DOI":"10.3389\/fcell.2022.964075","volume":"10","author":"H Zhang","year":"2022","unstructured":"Zhang H, et al. Role of A\u03b2 in Alzheimer\u2019s-related synaptic dysfunction. Front Cell Dev Biology. 2022;10:964075.","journal-title":"Front Cell Dev Biology"},{"issue":"1","key":"3713_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, et al. Recent advances in alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Therapy. 2024;9(1):211.","journal-title":"Signal Transduct Target Therapy"},{"issue":"11","key":"3713_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41582-022-00714-w","volume":"18","author":"L Migliore","year":"2022","unstructured":"Migliore L, Copped\u00e8 F. Gene\u2013environment interactions in alzheimer disease: the emerging role of epigenetics. Nat Reviews Neurol. 2022;18(11):643\u201360.","journal-title":"Nat Reviews Neurol"},{"issue":"13","key":"3713_CR13","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.3390\/ijms25136901","volume":"25","author":"MK Singh","year":"2024","unstructured":"Singh MK, et al. Comprehensive overview of alzheimer\u2019s disease: etiological insights and degradation strategies. Int J Mol Sci. 2024;25(13):6901.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3713_CR14","first-page":"423","volume":"29","author":"P Chan","year":"2021","unstructured":"Chan P, Valcour V. Neurocognition and the aging brain in people with HIV: implications for screening. Top Antiviral Med. 2021;29(5):423.","journal-title":"Top Antiviral Med"},{"issue":"3","key":"3713_CR15","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1093\/cid\/ciac658","volume":"76","author":"I Mastrorosa","year":"2023","unstructured":"Mastrorosa I, et al. Declining prevalence of human immunodeficiency virus (HIV)\u2013associated neurocognitive disorders in recent years and associated factors in a large cohort of antiretroviral therapy\u2013treated individuals with HIV. Clin Infect Dis. 2023;76(3):e629\u201337.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3713_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11481-008-9136-0","volume":"4","author":"J Xu","year":"2009","unstructured":"Xu J, Ikezu T. The comorbidity of HIV-associated neurocognitive disorders and alzheimer\u2019s disease: a foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol. 2009;4(2):200\u201312.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"7","key":"3713_CR17","doi-asserted-by":"publisher","first-page":"e504","DOI":"10.1016\/S2352-3018(20)30107-7","volume":"7","author":"A Winston","year":"2020","unstructured":"Winston A, Spudich S. Cognitive disorders in people living with HIV. Lancet HIV. 2020;7(7):e504\u201313.","journal-title":"Lancet HIV"},{"issue":"4","key":"3713_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, et al. HIV-associated neurocognitive disorder\u2014pathogenesis and prospects for treatment. Nat Reviews Neurol. 2016;12(4):234\u201348.","journal-title":"Nat Reviews Neurol"},{"key":"3713_CR19","doi-asserted-by":"publisher","first-page":"p100235","DOI":"10.1016\/j.bbih.2021.100235","volume":"13","author":"S Buckley","year":"2021","unstructured":"Buckley S, et al. The role of oxidative stress in HIV-associated neurocognitive disorders. Brain Behav Immunity-Health. 2021;13:p100235.","journal-title":"Brain Behav Immunity-Health"},{"issue":"8","key":"3713_CR20","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1097\/QAD.0000000000003556","volume":"37","author":"J Gonzalez","year":"2023","unstructured":"Gonzalez J, et al. Neuronal accumulation of hyperphosphorylated Tau protein predicts stable memory impairment in people living with HIV. Aids. 2023;37(8):1247\u201356.","journal-title":"Aids"},{"issue":"8","key":"3713_CR21","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/vaccines9080930","volume":"9","author":"DT Chemparthy","year":"2021","unstructured":"Chemparthy DT, et al. Alzheimer\u2019s-like pathology at the crossroads of hiv-associated neurological disorders. Vaccines. 2021;9(8):930.","journal-title":"Vaccines"},{"issue":"1","key":"3713_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/07853890.2020.1814962","volume":"53","author":"A Borrajo","year":"2021","unstructured":"Borrajo A, et al. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis. Ann Med. 2021;53(1):43\u201369.","journal-title":"Ann Med"},{"issue":"5","key":"3713_CR23","doi-asserted-by":"publisher","first-page":"101576","DOI":"10.1016\/j.gendis.2025.101576","volume":"12","author":"HD Nguyen","year":"2025","unstructured":"Nguyen HD, Kim WK. New genetic insights into HIV-associated neurocognitive disorder and Alzheimer's disease. Genes Dis. 2025;12(5):101576. https:\/\/doi.org\/10.1016\/j.gendis.2025.101576.","journal-title":"Genes Dis"},{"issue":"1","key":"3713_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, et al. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Therapy. 2023;8(1):267.","journal-title":"Signal Transduct Target Therapy"},{"issue":"39","key":"3713_CR25","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1523\/JNEUROSCI.0682-22.2022","volume":"42","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, et al. STAT1 contributes to microglial\/macrophage inflammation and neurological dysfunction in a mouse model of traumatic brain injury. J Neurosci. 2022;42(39):7466\u201381.","journal-title":"J Neurosci"},{"issue":"7","key":"3713_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/cells13070581","volume":"13","author":"T Ageeva","year":"2024","unstructured":"Ageeva T, Rizvanov A, Mukhamedshina Y. NF-\u03baB and JAK\/STAT signaling pathways as crucial regulators of neuroinflammation and astrocyte modulation in spinal cord injury. Cells. 2024;13(7):581.","journal-title":"Cells"},{"issue":"1","key":"3713_CR27","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/ijms24010864","volume":"24","author":"M Rusek","year":"2023","unstructured":"Rusek M, et al. The role of the JAK\/STAT signaling pathway in the pathogenesis of alzheimer\u2019s disease: new potential treatment target. Int J Mol Sci. 2023;24(1):864.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3713_CR28","doi-asserted-by":"publisher","first-page":"e28259","DOI":"10.1002\/jmv.28259","volume":"95","author":"W Zhang","year":"2023","unstructured":"Zhang W, et al. The emerging roles of IFIT3 in antiviral innate immunity and cellular biology. J Med Virol. 2023;95(1):e28259.","journal-title":"J Med Virol"},{"issue":"6","key":"3713_CR29","doi-asserted-by":"publisher","first-page":"e02829","DOI":"10.1128\/mBio.02829-21","volume":"12","author":"A Chikhalya","year":"2021","unstructured":"Chikhalya A, et al. Human IFIT3 protein induces interferon signaling and inhibits adenovirus immediate early gene expression. MBio. 2021;12(6):e02829\u201321.","journal-title":"MBio"},{"issue":"2","key":"3713_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/v15020342","volume":"15","author":"JH Franco","year":"2023","unstructured":"Franco JH, Chattopadhyay S, Pan ZK. How different pathologies are affected by IFIT expression. Viruses. 2023;15(2):342.","journal-title":"Viruses"},{"key":"3713_CR31","doi-asserted-by":"publisher","first-page":"1439837","DOI":"10.3389\/fmolb.2024.1439837","volume":"11","author":"G Chen","year":"2024","unstructured":"Chen G, et al. Unraveling the roles of IFIT3 gene and immune-metabolic pathways in psoriasis: A bioinformatics exploration for diagnostic markers and therapeutic targets. Front Mol Biosci. 2024;11:1439837.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"3713_CR32","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1038\/s41598-022-27276-7","volume":"13","author":"A Garces","year":"2023","unstructured":"Garces A, et al. Differential expression of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in alzheimer\u2019s disease and HIV-1 associated neurocognitive disorders. Sci Rep. 2023;13(1):3276.","journal-title":"Sci Rep"},{"key":"3713_CR33","doi-asserted-by":"publisher","first-page":"1515718","DOI":"10.3389\/fimmu.2025.1515718","volume":"16","author":"R Wu","year":"2025","unstructured":"Wu R, Yang H, Liu C. IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications. Front Immunol. 2025;16:1515718.","journal-title":"Front Immunol"},{"key":"3713_CR34","doi-asserted-by":"publisher","first-page":"1008072","DOI":"10.3389\/fimmu.2022.1008072","volume":"13","author":"R Lang","year":"2022","unstructured":"Lang R, et al. Expression and mechanisms of interferon-stimulated genes in viral infection of the central nervous system (CNS) and neurological diseases. Front Immunol. 2022;13:1008072.","journal-title":"Front Immunol"},{"issue":"3","key":"3713_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/imm.13181","volume":"160","author":"H Liu","year":"2020","unstructured":"Liu H, et al. HIV infection suppresses TLR3 activation-mediated antiviral immunity in microglia and macrophages. Immunology. 2020;160(3):269\u201379.","journal-title":"Immunology"},{"issue":"1","key":"3713_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13365-016-0472-1","volume":"23","author":"P Rawat","year":"2017","unstructured":"Rawat P, Spector SA. Development and characterization of a human microglia cell model of HIV-1 infection. J Neurovirol. 2017;23(1):33\u201346.","journal-title":"J Neurovirol"},{"issue":"2","key":"3713_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11064-025-04357-3","volume":"50","author":"A Graur","year":"2025","unstructured":"Graur A, et al. HIV-1 gp120 interactions with nicotine modulate mitochondrial network properties and amyloid release in microglia. Neurochem Res. 2025;50(2):103.","journal-title":"Neurochem Res"},{"issue":"8","key":"3713_CR38","doi-asserted-by":"publisher","first-page":"e0307735","DOI":"10.1371\/journal.pone.0307735","volume":"19","author":"C Xia","year":"2024","unstructured":"Xia C, et al. Ginkgo Biloba extract inhibits hippocampal neuronal injury caused by mitochondrial oxidative stress in a rat model of alzheimer\u2019s disease. PLoS ONE. 2024;19(8):e0307735.","journal-title":"PLoS ONE"},{"key":"3713_CR39","doi-asserted-by":"publisher","first-page":"112880","DOI":"10.1016\/j.biopha.2022.112880","volume":"149","author":"B Wiatrak","year":"2022","unstructured":"Wiatrak B, et al. Effect of amyloid-\u03b2 on the redox system activity in SH-SY5Y cells preincubated with lipopolysaccharide or co-cultured with microglia cells. Biomed Pharmacother. 2022;149:112880.","journal-title":"Biomed Pharmacother"},{"key":"3713_CR40","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bioactmat.2023.01.006","volume":"24","author":"J Kim","year":"2023","unstructured":"Kim J, et al. Potential alzheimer\u2019s disease therapeutic nano-platform: discovery of amyloid-beta plaque disaggregating agent and brain-targeted delivery system using porous silicon nanoparticles. Bioactive Mater. 2023;24:497\u2013506.","journal-title":"Bioactive Mater"},{"issue":"1","key":"3713_CR41","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1038\/s41598-017-01798-x","volume":"7","author":"Y-q Liu","year":"2017","unstructured":"Liu Y-q, et al. Arrestins contribute to amyloid beta-induced cell death via modulation of autophagy and the \u03b17nAch receptor in SH-SY5Y cells. Sci Rep. 2017;7(1):3446.","journal-title":"Sci Rep"},{"issue":"11","key":"3713_CR42","doi-asserted-by":"publisher","first-page":"10912","DOI":"10.18632\/aging.103305","volume":"12","author":"Z Long","year":"2020","unstructured":"Long Z, et al. Dynamic changes of autophagic flux induced by Abeta in the brain of postmortem alzheimer\u2019s disease patients, animal models and cell models. Aging. 2020;12(11):10912.","journal-title":"Aging"},{"issue":"6","key":"3713_CR43","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/jnc.15143","volume":"156","author":"S Mosser","year":"2021","unstructured":"Mosser S, Gerber H, Fraering PC. Identification of truncated C-terminal fragments of the alzheimer\u2019s disease amyloid protein precursor derived from sequential proteolytic pathways. J Neurochem. 2021;156(6):943\u201356.","journal-title":"J Neurochem"},{"key":"3713_CR44","first-page":"1","volume":"2","author":"MJ V\u00e9gh","year":"2014","unstructured":"V\u00e9gh MJ, et al. Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of alzheimer\u2019s disease. Acta Neuropathol Commun. 2014;2:1\u201311.","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"3713_CR45","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3945\/jn.112.169516","volume":"143","author":"L Rojanathammanee","year":"2013","unstructured":"Rojanathammanee L, Puig KL, Combs CK. Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a Transgenic mouse model of alzheimer disease. J Nutr. 2013;143(5):597\u2013605.","journal-title":"J Nutr"},{"issue":"2","key":"3713_CR46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/biomedicines10020305","volume":"10","author":"A Jullienne","year":"2022","unstructured":"Jullienne A, Trinh MV, Obenaus A. Neuroimaging of mouse models of alzheimer\u2019s disease. Biomedicines. 2022;10(2):305.","journal-title":"Biomedicines"},{"issue":"9","key":"3713_CR47","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/bios13090852","volume":"13","author":"A Meah","year":"2023","unstructured":"Meah A, et al. Single-Cell Spatial MIST for Versatile, scalable detection of protein markers. Biosensors. 2023;13(9):852.","journal-title":"Biosensors"},{"key":"3713_CR48","doi-asserted-by":"publisher","first-page":"1532318","DOI":"10.3389\/fimmu.2025.1532318","volume":"16","author":"RK Das","year":"2025","unstructured":"Das RK, et al. IFIT3 activation significantly contributes to HIV-1-Associated neurodegenerative disorder (HAND)-Mediated neuroinflammation. Front Immunol. 2025;16:1532318.","journal-title":"Front Immunol"},{"issue":"13","key":"3713_CR49","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2217\/nnm-2022-0043","volume":"17","author":"CR Garcia","year":"2022","unstructured":"Garcia CR, et al. Effect of drug-to-lipid ratio on nanodisc-based Tenofovir drug delivery to the brain for HIV-1 infection. Nanomedicine. 2022;17(13):959\u201378.","journal-title":"Nanomedicine"},{"key":"3713_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fncel.2018.00307","volume":"12","author":"G Canet","year":"2018","unstructured":"Canet G, et al. HIV neuroinfection and alzheimer\u2019s disease: similarities and potential links? Front Cell Neurosci. 2018;12:307.","journal-title":"Front Cell Neurosci"},{"key":"3713_CR51","doi-asserted-by":"publisher","unstructured":"Pyun JM, Park YH, Hodges A, Jang JW, Bice PJ, Kim S, et al. Immunity gene IFITM3 variant: Relation to cognition and Alzheimer's disease pathology. Alzheimers Dement (Amsterdam, Netherlands). 2022;14(1):e12317. https:\/\/doi.org\/10.1002\/dad2.12317.","DOI":"10.1002\/dad2.12317"},{"issue":"19","key":"3713_CR52","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1021\/acschemneuro.5c00475","volume":"16","author":"X Shao","year":"2025","unstructured":"Shao X, Sun J, Wang X, Yin XS, Chen Z, Xu Y, et al. Intraventricular creatine treatment attenuates Alzheimer's disease-related neuropathological changes and memory impairment via inhibiting STAT1 phosphorylation. ACS Chem Neurosci. 2025;16(19):3790\u2013800. https:\/\/doi.org\/10.1021\/acschemneuro.5c00475.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"3713_CR53","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12967-025-06112-2","volume":"23","author":"Z Xie","year":"2025","unstructured":"Xie Z, et al. Critical role of Oas1g and STAT1 pathways in neuroinflammation: insights for alzheimer\u2019s disease therapeutics. J Translational Med. 2025;23(1):182.","journal-title":"J Translational Med"},{"issue":"1","key":"3713_CR54","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13195-025-01818-3","volume":"17","author":"L Kong","year":"2025","unstructured":"Kong L, et al. Periodontitis-induced neuroinflammation triggers IFITM3-A\u03b2 axis to cause alzheimer\u2019s disease-like pathology and cognitive decline. Alzheimers Res Ther. 2025;17(1):166.","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"3713_CR55","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.cell.2024.02.020","volume":"187","author":"CC Escoubas","year":"2024","unstructured":"Escoubas CC, et al. Type-I-interferon-responsive microglia shape cortical development and behavior. Cell. 2024;187(8):1936\u201354. e24.","journal-title":"Cell"},{"issue":"4","key":"3713_CR56","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy ER, et al. Type I interferon response drives neuroinflammation and synapse loss in alzheimer disease. J Clin Investig. 2020;130(4):1912\u201330.","journal-title":"J Clin Investig"},{"key":"3713_CR57","first-page":"101659","volume":"38","author":"J-Y Kim","year":"2024","unstructured":"Kim J-Y, et al. NF-\u03baB p65 and TCF-4 interactions are associated with LPS-stimulated IL-6 secretion of macrophages. Biochem Biophys Rep. 2024;38:101659.","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"3713_CR58","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/ph18010104","volume":"18","author":"R Mallick","year":"2025","unstructured":"Mallick R, et al. Targeting cytokine-mediated inflammation in brain disorders: developing new treatment strategies. Pharmaceuticals. 2025;18(1):104.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"3713_CR59","first-page":"1","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, et al. NF-\u03baB signaling in inflammation. Signal Transduct Target Therapy. 2017;2(1):1\u20139.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"3713_CR60","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12974-020-02041-7","volume":"18","author":"H Wu","year":"2021","unstructured":"Wu H, et al. Mer regulates microglial\/macrophage M1\/M2 polarization and alleviates neuroinflammation following traumatic brain injury. J Neuroinflamm. 2021;18(1):2.","journal-title":"J Neuroinflamm"},{"issue":"10","key":"3713_CR61","doi-asserted-by":"publisher","first-page":"e011057","DOI":"10.1136\/jitc-2024-011057","volume":"13","author":"S Traxel","year":"2025","unstructured":"Traxel S, et al. Macrophages expressing chimeric cytokine receptors have an inflammatory phenotype and antitumoral activity upon IL-10 or TGF\u03b2 stimulation. J Immunother Cancer. 2025;13(10):e011057.","journal-title":"J Immunother Cancer"},{"key":"3713_CR62","doi-asserted-by":"publisher","unstructured":"Navabi SP, Badreh F, Khombi Shooshtari M, Hajipour S, Moradi Vastegani S, Khoshnam SE. Microglia-induced neuroinflammation in hippocampal neurogenesis following traumatic brain injury. Heliyon. 2024;10(16):e35869. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35869.","DOI":"10.1016\/j.heliyon.2024.e35869"},{"issue":"4","key":"3713_CR63","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","volume":"19","author":"DA Green","year":"2005","unstructured":"Green DA, et al. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. Aids. 2005;19(4):407\u201311.","journal-title":"Aids"},{"issue":"1","key":"3713_CR64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13195-015-0123-4","volume":"7","author":"RA Cohen","year":"2015","unstructured":"Cohen RA, Seider TR, Navia B. HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? Alzheimers Res Ther. 2015;7(1):37. https:\/\/doi.org\/10.1186\/s13195-015-0123-4.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"3713_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11481-008-9143-1","volume":"4","author":"BJ Brew","year":"2009","unstructured":"Brew BJ, et al. Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol. 2009;4(2):163\u201374.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"4","key":"3713_CR66","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11481-014-9546-0","volume":"9","author":"M Ortega","year":"2014","unstructured":"Ortega M, Ances BM. Role of HIV in amyloid metabolism. J Neuroimmune Pharmacol. 2014;9(4):483\u201391.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"18","key":"3713_CR67","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1097\/QAD.0b013e32835a117c","volume":"26","author":"V Soontornniyomkij","year":"2012","unstructured":"Soontornniyomkij V, et al. Cerebral \u03b2-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE \u03b54 carriers. Aids. 2012;26(18):2327\u201335.","journal-title":"Aids"},{"issue":"14","key":"3713_CR68","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1097\/QAD.0000000000002336","volume":"33","author":"A Umlauf","year":"2019","unstructured":"Umlauf A, et al. Risk of developing cerebral \u03b2-amyloid plaques with posttranslational modification among HIV-infected adults. AIDS. 2019;33(14):2157\u201366.","journal-title":"AIDS"},{"issue":"12","key":"3713_CR69","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/jnen\/nlaf102","volume":"84","author":"TD Zaikos","year":"2025","unstructured":"Zaikos TD, Guo H, Barrett A, Dastgheyb R, Rubin LH, Troncoso J, et al. Neuropathologic findings in a community-based autopsy cohort of older, virally suppressed, people with HIV. J Neuropathol Exp Neurol. 2025;84(12):1094\u2013105. https:\/\/doi.org\/10.1093\/jnen\/nlaf102.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3713_CR70","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3389\/fimmu.2020.01030","volume":"11","author":"Z Ren","year":"2020","unstructured":"Ren Z, et al. Regulation of MAVS expression and signaling function in the antiviral innate immune response. Front Immunol. 2020;11:1030.","journal-title":"Front Immunol"},{"key":"3713_CR71","doi-asserted-by":"publisher","first-page":"109594","DOI":"10.1016\/j.vetmic.2022.109594","volume":"275","author":"F Xu","year":"2022","unstructured":"Xu F, et al. IFIT3 mediated the type I interferon antiviral response by targeting senecavirus A entry, assembly and release pathways. Vet Microbiol. 2022;275:109594.","journal-title":"Vet Microbiol"},{"issue":"3","key":"3713_CR72","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/v11030246","volume":"11","author":"CL Ashley","year":"2019","unstructured":"Ashley CL, et al. Interferon-independent upregulation of interferon-stimulated genes during human cytomegalovirus infection is dependent on IRF3 expression. Viruses. 2019;11(3):246.","journal-title":"Viruses"},{"issue":"800","key":"3713_CR73","doi-asserted-by":"publisher","first-page":"eadr5300","DOI":"10.1126\/scitranslmed.adr5300","volume":"17","author":"W Cui","year":"2025","unstructured":"Cui W, et al. Interferon regulatory factor-1\u2013expressing astrocytes are epigenetically controlled and exacerbate TBI-associated pathology in mice. Sci Transl Med. 2025;17(800):eadr5300.","journal-title":"Sci Transl Med"},{"key":"3713_CR74","doi-asserted-by":"publisher","unstructured":"Stach LM, Huis In 't Veld LGM, Schaub T, Jendrach M, Ornaghi M, Schwabenland M, et al. Decoding IFN-mediated immunity and cell dynamics in viral encephalitis: insights from coxsackievirus B3 infection. iScience, 2025;29(1):114324. https:\/\/doi.org\/10.1016\/j.isci.2025.114324.","DOI":"10.1016\/j.isci.2025.114324"},{"key":"3713_CR75","doi-asserted-by":"publisher","first-page":"856376","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, et al. Microglia in the neuroinflammatory pathogenesis of alzheimer\u2019s disease and related therapeutic targets. Front Immunol. 2022;13:856376.","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"3713_CR76","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0165-5728(03)00009-2","volume":"136","author":"G Flynn","year":"2003","unstructured":"Flynn G, et al. Regulation of chemokine receptor expression in human microglia and astrocytes. J Neuroimmunol. 2003;136(1\u20132):84\u201393.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"3713_CR77","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12977-020-00544-y","volume":"17","author":"MA Rai","year":"2020","unstructured":"Rai MA, et al. Comparative analysis of human microglial models for studies of HIV replication and pathogenesis. Retrovirology. 2020;17(1):35.","journal-title":"Retrovirology"},{"issue":"2","key":"3713_CR78","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/v15020424","volume":"15","author":"EM Moss","year":"2023","unstructured":"Moss EM, et al. Physiological corticosterone attenuates gp120-Mediated microglial activation and is associated with reduced Anxiety-Like behavior in gp120-Expressing mice. Viruses. 2023;15(2):424.","journal-title":"Viruses"},{"issue":"2","key":"3713_CR79","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11481-020-09936-5","volume":"16","author":"TJ Arabatzis","year":"2021","unstructured":"Arabatzis TJ, et al. Effects of HIV gp120 on neuroinflammation in immunodeficient vs. immunocompetent States. J Neuroimmune Pharmacol. 2021;16(2):437\u201353.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"13","key":"3713_CR80","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1089\/aid.1996.12.1209","volume":"12","author":"VA SHATROV","year":"1996","unstructured":"SHATROV VA, et al. HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-kB activation in Jurkat cells. AIDS Res Hum Retroviruses. 1996;12(13):1209\u201316.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3713_CR81","doi-asserted-by":"publisher","unstructured":"Peng Q, Qiao J, Li W, You Q, Hu S, Liu Y, et al. Global m6A methylation and gene expression patterns in human microglial HMC3 cells infected with HIV-1. Heliyon. 2023;9(11):e21307. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21307.","DOI":"10.1016\/j.heliyon.2023.e21307"},{"issue":"2","key":"3713_CR82","first-page":"76","volume":"21","author":"M Santerre","year":"2019","unstructured":"Santerre M, et al. Differential contribution of HIV-1 subtypes B and C to neurological disorders: mechanisms and possible treatments. AIDS Rev. 2019;21(2):76.","journal-title":"AIDS Rev"},{"issue":"1","key":"3713_CR83","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12985-024-02419-6","volume":"21","author":"PT Gotora","year":"2024","unstructured":"Gotora PT, et al. Impact of subtype C-specific amino acid variants on HIV-1 Tat-TAR interaction: insights from molecular modelling and dynamics. Virol J. 2024;21(1):144.","journal-title":"Virol J"},{"issue":"1","key":"3713_CR84","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1038\/s41598-019-39531-5","volume":"9","author":"AP Ruiz","year":"2019","unstructured":"Ruiz AP, et al. A naturally occurring polymorphism in the HIV-1 Tat basic domain inhibits uptake by bystander cells and leads to reduced neuroinflammation. Sci Rep. 2019;9(1):3308.","journal-title":"Sci Rep"},{"issue":"4","key":"3713_CR85","doi-asserted-by":"publisher","first-page":"e34726","DOI":"10.1371\/journal.pone.0034726","volume":"7","author":"E Hoxha","year":"2012","unstructured":"Hoxha E, et al. Excitability and synaptic alterations in the cerebellum of APP\/PS1 mice. PLoS ONE. 2012;7(4):e34726.","journal-title":"PLoS ONE"},{"issue":"1","key":"3713_CR86","doi-asserted-by":"publisher","first-page":"32943","DOI":"10.1038\/s41598-025-12975-8","volume":"15","author":"D Van Rossem","year":"2025","unstructured":"Van Rossem D, et al. Assessing the link between cerebellar volume and cognitive function in alzheimer\u2019s disease: a pilot study. Sci Rep. 2025;15(1):32943.","journal-title":"Sci Rep"},{"issue":"1","key":"3713_CR87","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/brain\/awx194","volume":"141","author":"HI Jacobs","year":"2018","unstructured":"Jacobs HI, et al. The cerebellum in alzheimer\u2019s disease: evaluating its role in cognitive decline. Brain. 2018;141(1):37\u201347.","journal-title":"Brain"},{"issue":"7","key":"3713_CR88","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1080\/01616412.2021.1893566","volume":"43","author":"K Chaudhari","year":"2021","unstructured":"Chaudhari K, et al. Early loss of cerebellar purkinje cells in human and a Transgenic mouse model of alzheimer\u2019s disease. Neurol Res. 2021;43(7):570\u201381.","journal-title":"Neurol Res"},{"issue":"2","key":"3713_CR89","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3233\/JAD-160572","volume":"54","author":"L Ordo\u00f1ez-Gutierrez","year":"2016","unstructured":"Ordo\u00f1ez-Gutierrez L, et al. A\u03b2PP\/PS1 Transgenic mice show sex differences in the cerebellum associated with aging. J Alzheimer\u2019s Disease. 2016;54(2):645\u201356.","journal-title":"J Alzheimer\u2019s Disease"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03713-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03713-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03713-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:01:52Z","timestamp":1775613712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03713-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3713"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03713-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Postmortem human brain tissues from individuals with Alzheimer\u2019s disease and HIV-associated neurocognitive disorder were obtained from the University of California, San Diego Alzheimer\u2019s Disease Research Center (IRB #170957) and the National NeuroAIDS Tissue Consortium (IRB #080323), respectively.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}